Glenmark Pharmaceuticals
GLENMARK.NS
#2606
Rank
ยฃ4.28 B
Marketcap
ยฃ15.18
Share price
-0.14%
Change (1 day)
98.65%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): ยฃ0.09994

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is ยฃ0.08499. In 2022 the company made an earnings per share (EPS) of ยฃ0.30 a decrease over its 2021 EPS that were of ยฃ0.38.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.09994-66.82%
2022ยฃ0.30-20.18%
2021ยฃ0.387.13%
2020ยฃ0.3525.72%
2019ยฃ0.28-22.01%
2018ยฃ0.3630.15%
2017ยฃ0.28-34.82%
2016ยฃ0.4263.09%
2015ยฃ0.269.68%
2014ยฃ0.24-26.58%
2013ยฃ0.320.51%
2012ยฃ0.32